Diabetes

Testing

Centers

Care Clinics®



Home of the

Free Foot Screenings








Medical Providers ONLY

Reverse Diabetes Complications

Clinically Proven Reductions

DTC Care Clinics®

DTC Care Clinics® empower providers to perform non-invasive FDA Cleared screenings and assessments reducing referrals while delivering timely results and early detection—all in one convenient location.  

Welcome Providers!

Diabetes Testing Centers (DTC) was founded 15 years ago with a mission to empower private medical practices through fee-for-service (FFS) solutions focused on type 2 diabetes and chronic conditions. Today, DTC continues to support practices with integrated, noninvasive FDA Cleared Screenings and Health Risk Assessments (HRAs) that identify individuals who may be diabetic or prediabetic. These assessments are eligible for reimbursement through CMS and Medicare Advantage programs, making them a cost-effective solution for practices. By providing proactive, preventive services, DTC helps deliver better patient outcomes while ensuring reliable revenue growth for our partner practices. 

Built on its strong foundation in diabetes care, DTC Care Clinics® offer high-demand and innovative healthcare opportunities to transform a portion—or even the entirety—of medical practices. The programs elevate clinics to offer specialized services into comprehensive, dedicated programs tailored to address widely sought-after healthcare services such as:

By diversifying our services, providers can attract a broader range of patients, including those with non-diabetic conditions, while addressing critical chronic health issues. This expansion not only enhances patient care but also strengthens your practice’s reputation and creates a sustainable pathway for increased revenue growth.

As a premier strategic partner for revenue growth, DTC can equips clinics with the tools, resources, and flexibility needed to thrive in today’s healthcare landscape. With flexible options for equipment purchase or rental and leveraging our partnership with the nation’s largest non-acute Group Purchasing Organization (GPO)—supporting over 20,000 clinics—DTC helps practices significantly reduce operational costs, enhance efficiency, and maximize reimbursements through accurate, compliant billing for maximum reimbursements. 

Improve Reputation and Revenue

Health Risk Assessments

Our CardioANS is a low-cost tool to screen for heart failure (HF), enabling early detection and timely referral for further cardiac evaluation. 

À La Carte Services

DTC offers more than just advanced health-risk assessments, we provide a no or low-risk and high-reward opportunity to invest in your own success. By integrating DTC's customized diagnostics into their practices, providers are not only enhancing patient care but also significantly elevating their professional value and growth with little or zero down (OAC). DTC enables clinics to seamlessly incorporate testing services into their existing offerings with ease and flexibility.

Providers can choose from a variety of quick, non-invasive, and reimbursable tests that align perfectly with their practice management. This level of customization not only improves diagnostic accuracy and patient outcomes but also opens new revenue streams through specialized, in-house testing services, all while minimizing or eliminating financial risk. This approach ensures that clinics can meet the unique needs of their patient populations efficiently. 

Providers, partnering with DTC is a strategic investment in the future of your practice and personalized care, all while upholding CMS compliance standards. This collaboration places you at the forefront of healthcare innovation and promises exceptional patient outcomes. It’s not just an investment in technology and services; it’s an investment in your practice, your patients, and the significant changes you can make by enhancing the standard of care.

Instant Revenue on Day One

Click here to see more of our assessments that can impact your practice (mix and match combos).

Compliance & Revenue

DTC Care Clinics® empower single provider practices to operate as efficiently as a multiple provider practice.

Start Working Smarter

Comprehensive and Reimbursable

At DTC, we recognize that diabetes care is not a one-size-fits-all solution. We offer a wide range of diagnostic assessments, empowering healthcare providers to manage diabetes from early detection to the management of complex complications. This tailored approach allows clinics of all sizes to focus on diabetes care, enhancing both patient outcomes and clinic performance.

This flexible model ensures that every clinic, regardless of size, can effectively address diabetes-related health challenges.

Strategic Focus

Even if a clinic cannot implement the full range of assessments, prioritizing one key area such as cardiovascular risk, peripheral arterial disease, or neuropathy can significantly enhance patient outcomes and clinic revenue. For example, a portable handheld AI fundus camera can diagnose diabetic retinopathy autonomously in under 60 seconds, eliminating the need for specialist referrals, closing crucial care gaps and receiving rebates from health plans.

Revenue Model

Beyond improved patient care, this model also offers financial advantages. Clinics can generate substantial revenue by offering reimbursable tests under Medicare and Medicaid, ensuring these essential diagnostics are accessible to a broad patient population. Adopting this diabetes-centric philosophy leads to better care and stronger financial health for clinics.

Reimbursable by Medicare Advantage

Provider Bundles

All of our Provider Bundles are based on devices reviewed and recognized by the FDA to ensure safety, effectiveness, and clinical outcomes.  

Identify Risks Early 

Diabetes Testing Centers (DTC) offers a range of comprehensive provider bundles specifically designed for various medical specialties. These bundles seamlessly integrate into existing workflows, enabling providers to deliver targeted, effective care without disruption. Each bundle includes assessments and therapies that meet the unique needs of patients managing diabetes and related chronic conditions, helping to enhance health outcomes.

DTC's approach addresses the high-risk morbidities and mortalities often associated with diabetes and related conditions, many of which can go unchecked without targeted care. By incorporating specialized assessments and management tools across medical specialties, DTC supports providers in delivering comprehensive, proactive care for patients with complex health needs.

These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience.

Reduce Morbidities and Mortalities

Identify Cardiovascular Conditions Early

Long COVID Consequences

Cardiovascular disease is the leading cause of death for both men and women, posing a significant risk to diabetes patients, as heart attacks and strokes can be fatal and overshadow other diabetes-related conditions. The risk is even higher for individuals who have had COVID-19, as the virus can worsen cardiovascular issues, leading to complications like myocarditis and blood clots. Therefore, testing for cardiovascular risk factors is critical for early identification and management, which can help prevent life-threatening events such as heart attacks or strokes with the CardioANS.

For individuals with Long COVID, especially those with cardiovascular symptoms, primary care testing is crucial to determine if comprehensive imaging, such as echocardiograms, is necessary to evaluate the left ventricle. Monitoring the left ventricle is essential for developing interventions to address the virus’s lasting cardiovascular effects. Additionally, cognitive assessments should be performed to address 'brain fog' in post-COVID patients.

Key Features


Left ventricular systolic dysfunction (LVSD) increases heart failure risk nearly 5x compared to normal function 

Kannel WB, Gordon T, and National Heart Institute (U.S.) (1968) The Framingham study: An epidemiological investigation of cardiovascular disease. Bethesda, MD., United States. Department of Health, Education, and Welfare, National Institutes of Health.

Schedule Below to Learn More

Go Beyond Blood Sugars